| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 2 974-981, Copyright © 1995 by American Association of Immunologists
ARTICLES |
M Makino, K Yoshimatsu, M Azuma, Y Okada, Y Hitoshi, H Yagita, K Takatsu and K Komuro
Department of Bacterial and Blood Products, National Institute of Health Japan, Tokyo.
Murine AIDS (MAIDS) is induced by infection with the replication- defective virus (BM5def) component in the LP-BM5 murine leukemia virus (MuLV) mixture. The disease is characterized by polyclonally activated CD4+ T cells and B cells. It is known that BM5def is expressed at highest levels in B lymphocytes and that B cells serve as viral antigen- presenting cells. Full and sustained activation of CD4+ T cells against a conventional Ag usually requires both TCR and costimulating signals. Among various molecules known to provide costimulatory function, the expression of CD54 (ICAM-1) and CD11a/CD18 (LFA-1) on MAIDS B cells was increased, whereas that of CD2, heat-stable Ag (CD24), CD80 (B7-1), and CD86 (B7-2) was unchanged from normal. C57BL/6 mice depleted of both CD54 and CD11a expression as a result of chronic administration of mAb had developed no MAIDS at 4 wk and 8 wk after LP-BM5 MuLV infection. In addition, the proliferative response of B cells to mitogen was well conserved, whereas MAIDS-associated increases in serum Ig levels were inhibited. Replication of BM5def was suppressed markedly in infected mice treated with the CD54 and CD11a mAbs. These results suggest that the CD54/CD11a signal transduction pathway is a critical determinant of MAIDS development, and the lack of an immune response against viral Ag is enough to suppress BM5def replication and to prevent MAIDS.
This article has been cited by other articles:
|
|
 |
|
  S. M. Knoetig, T. A. Torrey, Z. Naghashfar, T. McCarty, and H. C. Morse III CD19 Signaling Pathways Play a Major Role for Murine AIDS Induction and Progression J. Immunol., November 15, 2002; 169(10): 5607 - 5614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Green, W. J. Cook, A. H. Sharpe, and W. R. Green The CD154/CD40 Interaction Required for Retrovirus-Induced Murine Immunodeficiency Syndrome Is Not Mediated by Upregulation of the CD80/CD86 Costimulatory Molecules J. Virol., November 13, 2002; 76(24): 13106 - 13110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Yen, N. Lepak, and S. L. Swain Induction of CD4 T Cell Changes in Murine AIDS Is Dependent on Costimulation and Involves a Dysregulation of Homeostasis J. Immunol., July 15, 2002; 169(2): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. MAUS, J. HUWE, L. ERMERT, M. ERMERT, W. SEEGER, and J. LOHMEYER Molecular Pathways of Monocyte Emigration into the Alveolar Air Space of Intact Mice Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Harris, S. Koch, L. M. Mullen, and S. L. Swain B Cell Immunodeficiency Fails to Develop in CD4-Deficient Mice Infected with BM5: Murine AIDS as a Multistep Disease J. Immunol., May 15, 2001; 166(10): 6041 - 6049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Green, R. J. Noelle, B. G. Durell, and W. R. Green Characterization of the CD154-Positive and CD40-Positive Cellular Subsets Required for Pathogenesis in Retrovirus-Induced Murine Immunodeficiency J. Virol., April 15, 2001; 75(8): 3581 - 3589. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Makino, M. Azuma, S.-I. Wakamatsu, Y. Suruga, S. Izumo, M. M. Yokoyama, and M. Baba Marked Suppression of T Cells by a Benzothiophene Derivative in Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Clin. Vaccine Immunol., May 1, 1999; 6(3): 316 - 322. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
